跳至主要内容
临床试验/NCT05560022
NCT05560022撤回不适用

Study of the Total Hip Prosthesis With a HYPE Stem in Hip Arthroplasty

Societe dEtude, de Recherche et de Fabrication2 个研究点 分布在 1 个国家目标入组 180 人开始时间: 2017年12月5日最近更新:
适应症

试验速览

阶段
不适用
状态
撤回
发起方
入组人数
180
试验地点
2
主要终点
Assess the Survival rate to Total Hip Prothesis combining a HYPE stem and a SERF cup in hip replacements

研究概览

简要总结

The purpose of this study is to validate the performance and the safety of the HYPE (SERF) prothesis in compliance with the 93/42/EEC directive and in relation to the recommendations of the MEDDEV 2.7.1 guide ( guideline for post-market follow-up), which provides for the implementation of a systematic procedure for the follow-up of clinical data in order to verify the performance claimed for medical devices .

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Man or women
  • Degenerative or inflammatory hip pathology requiring a total hip replacement
  • Primary or secondary osteoarthritis
  • Advanced joint destruction resulting from rhumatoid arthritis or traumatic arthritis
  • Fracture or avascular necrosis
  • Sub-capital fracture and displaced transcervical as well as for bone defects stages I to IIb of PAPROSKY
  • Traumatic joint destruction
  • Following previous intervention, provided that the new device does not interfere with the material in place (osteosynthesis, joint reconstruction, arthrodesis, hemi-arthroplasty, total arthroplasty

排除标准

  • People with diminished mental faculties
  • Known current pregnancy
  • Breast-feeding
  • Neurological disorders or other pathologies that may influence locomotion
  • Septic antecedent on hip to operate
  • Patient requiring a bone graft

结局指标

主要结局

Assess the Survival rate to Total Hip Prothesis combining a HYPE stem and a SERF cup in hip replacements

时间窗: per operative period to 10 years

Survival according to Kaplan Meier

次要结局

  • Assess the improvement in PMA scores and HHS score as well as patient satisfaction(per operative period to 10 years)
  • Adverse events(per operative period to 10 years)
  • Patient satisfaction(per operative period to 10 years)

研究者

发起方
Societe dEtude, de Recherche et de Fabrication
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验